Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $7.972B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 36,179,665 | $2.061B | 25.9% | $72.80 | -17.5% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 10,568,897 | $1.653B | 20.7% | $136.93 | — | SPONSORED ADR | 07725L102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 42,864,612 | $793M | 9.9% | $18.93 | +30.9% | COM | 004225108 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,969,798 | $526M | 6.6% | $119.77 | +96.7% | COM | 558868105 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 6,398,365 | $277M | 3.5% | $23.49 | +86.3% | COM | 76243J105 |
| RVMD | Revolution Medicines, Inc. | 7,549,249 | $243M | 3.1% | $26.62 | +11.3% | COM | 76155X100 |
| KYMR | Kymera Therapeutics, Inc. | 5,995,928 | $241M | 3.0% | $28.14 | +27.2% | COM | 501575104 |
| ABCL | AbCellera Biologics Inc. | 27,525,640 | $125M | 1.6% | $21.02 | -75.7% | COM | 00288U106 |
| BCYC | Bicycle Therapeutics plc | 4,942,823 | $123M | 1.5% | $23.31 | — | SPONSORED ADS | 088786108 |
| EWTX | Edgewise Therapeutics, Inc. | 5,840,059 | $107M | 1.3% | $13.32 | +19.3% | COM | 28036F105 |
| IMCR | Immunocore Holdings plc | 1,515,318 | $98.5M | 1.2% | $42.57 | — | ADS | 45258D105 |
| KOD | Kodiak Sciences Inc. | 17,310,490 | $91.05M | 1.1% | $30.30 | -83.8% | COM | 50015M109 |
| ROIV | Roivant Sciences Ltd. | 7,413,834 | $78.14M | 1.0% | $8.98 | +20.0% | SHS | G76279101 |
| REPL | Replimune Group, Inc. | 9,545,336 | $77.99M | 1.0% | $15.29 | -46.4% | COM | 76029N106 |
| DNLI | Denali Therapeutics Inc. | 3,731,695 | $76.57M | 1.0% | $23.78 | -21.0% | COM | 24823R105 |
| TRDA | Entrada Therapeutics, Inc. | 4,865,819 | $68.95M | 0.9% | $16.96 | — | COM | 29384C108 |
| — | Akero Therapeutics, Inc. | 2,713,205 | $68.54M | 0.9% | $32.79 | — | COM | 00973Y108 |
| RARE | Ultragenyx Pharmaceutical Inc. | 1,466,547 | $68.47M | 0.9% | $65.34 | -27.8% | COM | 90400D108 |
| IMTX | Immatics N.V. | 6,443,398 | $67.72M | 0.8% | $10.87 | +7.3% | SHS | N44445109 |
| — | Cerevel Therapeutics Holdings, Inc. | 1,600,000 | $67.63M | 0.8% | $42.40 | — | COM | 15678U128 |
| ARGX | argenx SE | 151,215 | $59.54M | 0.7% | $79.01 | — | SPONSORED ADR | 04016X101 |
| NRIX | Nurix Therapeutics, Inc. | 3,882,125 | $57.07M | 0.7% | $22.27 | -51.7% | COM | 67080M103 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,809,577 | $55.43M | 0.7% | $17.35 | — | COM CL A | G5269C101 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 10,126,176 | $51.44M | 0.6% | $6.35 | -11.5% | COM | 09058V103 |
| — | Aerovate Therapeutics, Inc. | 1,680,517 | $49.69M | 0.6% | $21.15 | — | COM | 008064107 |
| SERA | Sera Prognostics, Inc. | 5,434,399 | $49.45M | 0.6% | $3.07 | +158.1% | CLASS A COM | 81749D107 |
| PRLD | Prelude Therapeutics Inc. | 10,123,824 | $47.99M | 0.6% | $28.24 | -86.2% | COM | 74065P101 |
| IDYA | IDEAYA Biosciences, Inc. | 1,062,123 | $46.61M | 0.6% | $14.62 | +194.0% | COM | 45166A102 |
| STOK | Stoke Therapeutics, Inc. | 3,368,443 | $45.47M | 0.6% | $7.82 | -22.6% | COM | 86150R107 |
| XENE | Xenon Pharmaceuticals Inc. | 993,679 | $42.78M | 0.5% | $18.51 | +148.6% | COM | 98420N105 |
| — | IGM Biosciences, Inc. | 4,088,322 | $39.45M | 0.5% | $15.73 | — | COM | 449585108 |
| CERS | Cerus Corporation | 19,477,339 | $36.81M | 0.5% | $4.19 | -51.3% | COM | 157085101 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4,916,095 | $34.66M | 0.4% | $6.49 | -8.7% | COM | 61225M102 |
| CELC | Celcuity Inc. | 1,552,478 | $33.53M | 0.4% | $13.85 | +15.3% | COM | 15102K100 |
| BMEA | Biomea Fusion, Inc. | 2,108,949 | $31.53M | 0.4% | $8.56 | +92.3% | COM | 09077A106 |
| KRYS | Krystal Biotech, Inc. | 169,934 | $30.24M | 0.4% | $34.45 | +303.2% | COM | 501147102 |
| SANA | Sana Biotechnology, Inc. | 2,380,949 | $23.81M | 0.3% | $4.55 | +64.5% | COM | 799566104 |
| NGNE | Neurogene Inc. | 456,015 | $23.21M | 0.3% | $14.32 | +133.2% | COM | 64135M105 |
| — | Verve Therapeutics, Inc. | 1,691,530 | $22.46M | 0.3% | $52.72 | — | COM | 92539P101 |
| TCRX | TScan Therapeutics, Inc. | 2,784,792 | $22.11M | 0.3% | $6.08 | +3.4% | COM | 89854M101 |
| ADAPY | Adaptimmune Therapeutics plc | 10,787,022 | $17.04M | 0.2% | $5.27 | — | SPONSORED ADR | 00653A107 |
| IMVT | Immunovant, Inc. | 425,009 | $13.73M | 0.2% | $22.60 | +61.4% | COM | 45258J102 |
| — | 2seventy bio, Inc. | 2,497,526 | $13.36M | 0.2% | $18.72 | — | COMMON STOCK | 901384107 |
| FATE | Fate Therapeutics, Inc. | 1,818,181 | $13.35M | 0.2% | $6.19 | 0.0% | COM | 31189P102 |
| XNCR | Xencor, Inc. | 545,431 | $12.07M | 0.2% | $22.46 | -3.8% | COM | 98401F105 |
| TSHA | Taysha Gene Therapies, Inc. | 4,004,756 | $11.49M | 0.1% | $1.91 | +8.8% | COM SHS | 877619106 |
| — | DBV Technologies S.A. | 14,614,264 | $10.95M | 0.1% | $19.06 | — | SPONSORED ADR | 23306J101 |
| CLDX | Celldex Therapeutics, Inc. | 247,644 | $10.39M | 0.1% | $29.41 | +39.6% | COM | 15117B202 |
| RLAY | Relay Therapeutics, Inc. | 1,160,117 | $9.629M | 0.1% | $13.78 | -29.2% | COM | 75943R102 |
| INSM | Insmed Incorporated | 343,000 | $9.306M | 0.1% | $19.59 | +42.9% | COM PAR $.01 | 457669307 |
| OPTEY | Opthea Limited | 2,177,826 | $8.951M | 0.1% | $11.12 | — | SPONSORED ADS | 68386J208 |
| NMRA | Neumora Therapeutics, Inc. | 633,851 | $8.715M | 0.1% | $16.17 | 0.0% | COM | 640979100 |
| — | Athira Pharma, Inc. | 3,153,807 | $8.641M | 0.1% | $6.91 | — | COM | 04746L104 |
| DYN | Dyne Therapeutics, Inc. | 285,000 | $8.091M | 0.1% | $22.62 | 0.0% | COM | 26818M108 |
| PRAX | Praxis Precision Medicines, Inc. | 131,533 | $8.026M | 0.1% | $44.86 | 0.0% | COM | 74006W207 |
| — | Sage Therapeutics, Inc. | 407,217 | $7.631M | 0.1% | $18.74 | — | COM | 78667J108 |
| SGMT | Sagimet Biosciences Inc. | 1,381,898 | $7.49M | 0.1% | $9.53 | -24.6% | COM SER A | 786700104 |
| PRME | Prime Medicine, Inc. | 1,028,466 | $7.199M | 0.1% | $18.06 | -58.0% | COM | 74168J101 |
| DSGN | Design Therapeutics, Inc. | 1,662,120 | $6.698M | 0.1% | $12.44 | -78.5% | COM | 25056L103 |
| TNGX | Tango Therapeutics, Inc. | 750,000 | $5.955M | 0.1% | $11.99 | -10.6% | COM | 87583X109 |
| — | HOOKIPA Pharma Inc. | 8,128,151 | $5.787M | 0.1% | $1.55 | — | COM | 43906K100 |
| — | Mersana Therapeutics, Inc. | 1,086,115 | $4.866M | 0.1% | $4.11 | — | COM | 59045L106 |
| MIRM | Mirum Pharmaceuticals, Inc. | 190,476 | $4.785M | 0.1% | $27.38 | +0.4% | COM | 604749101 |
| TLIS | Talis Biomedical Corporation | 508,323 | $4.448M | 0.1% | $7.25 | +13.7% | COM | 87424L207 |
| PCVX | Vaxcyte, Inc. | 48,885 | $3.339M | 0.0% | $39.24 | +76.5% | COM | 92243G108 |
| IPSC | Century Therapeutics, Inc. | 797,460 | $3.333M | 0.0% | $9.79 | -56.8% | COM | 15673T100 |
| — | Alpine Immune Sciences, Inc. | 81,578 | $3.234M | 0.0% | $39.64 | — | COM | 02083G100 |
| FDMT | 4D Molecular Therapeutics, Inc. | 100,000 | $3.186M | 0.0% | $25.51 | 0.0% | COM | 35104E100 |
| CYPH | Leap Therapeutics, Inc. | 1,172,175 | $3.118M | 0.0% | $5.02 | -40.3% | COM | 52187K200 |
| CMPX | Compass Therapeutics, Inc. | 1,557,630 | $3.084M | 0.0% | $3.99 | -56.7% | COM | 20454B104 |
| NAMS | NewAmsterdam Pharma Company N.V. | 96,827 | $2.29M | 0.0% | $20.30 | 0.0% | ORDINARY SHARES | N62509109 |
| VTVT | vTv Therapeutics, Inc. | 97,314 | $2.29M | 0.0% | $12.72 | 0.0% | CL A | 918385204 |
| KALA | KALA BIO, Inc. | 266,613 | $2.125M | 0.0% | $11.98 | -38.0% | COM | 483119202 |
| — | Aligos Therapeutics, Inc. | 2,076,400 | $2.035M | 0.0% | $24.92 | — | COM | 01626L105 |
| ELVN | Enliven Therapeutics, Inc. | 114,833 | $2.02M | 0.0% | $15.34 | 0.0% | COM | 29337E102 |
| — | Achilles Therapeutics plc | 1,208,775 | $1.511M | 0.0% | $16.55 | — | SPONSORED ADS | 00449L102 |
| — | Generation Bio Co. | 371,219 | $1.511M | 0.0% | $4.07 | — | COM | 37148K100 |
| — | Mural Oncology plc | 222,503 | $1.088M | 0.0% | $4.89 | — | ORD SHS | G63365103 |
| PFE | Pfizer Inc. | 35,000 | $971K | 0.0% | $26.40 | -6.6% | COM | 717081103 |
| TARA | Protara Therapeutics, Inc. | 199,671 | $801K | 0.0% | $30.96 | -89.6% | COM STK | 74365U107 |
| PMVP | PMV Pharmaceuticals, Inc. | 322,024 | $547K | 0.0% | $14.45 | -87.1% | COM | 69353Y103 |
| ACRV | Acrivon Therapeutics, Inc. | 52,885 | $378K | 0.0% | $4.64 | 0.0% | COMMON STOCK | 004890109 |
| FHTX | Foghorn Therapeutics Inc. | 45,027 | $302K | 0.0% | $14.37 | -61.4% | COM | 344174107 |
| CABA | Cabaletta Bio, Inc. | 13,331 | $227K | 0.0% | $8.14 | +163.7% | COM | 12674W109 |
| — | Perspective Therapeutics, Inc. | 149,787 | $178K | 0.0% | $0.39 | — | COM | 46489V104 |
| TYRA | Tyra Biosciences, Inc. | 10,607 | $174K | 0.0% | $12.95 | +26.7% | COM | 90240B106 |
| SRZNW | Surrozen, Inc. | 833,333 | $25,167 | 0.0% | $1.14 | — | W EXP 8/11/2026 | 86889P117 |